Our Pipeline
Prosemble’s drug pipeline is built on the synergy of AI-driven discovery and cutting-edge nanotechnology, aiming to redefine cancer treatment.
Next-Generation Drug Delivery
Harnessing AI and nanotechnology to improve precision, efficacy, and safety in cancer treatment.
Targeted & Responsive Therapies
Our platform ensures controlled drug release, minimising toxicity and maximising therapeutic impact.
Scalable & Cost-Effective Solutions
Innovative nanoparticle technology provides a more accessible alternative to traditional oncology treatments.
Our Pipeline
Doxorubicin (interferes with the growth and spread of cancer cells). Works on Breast cancer, bladder cancer, Kaposi’s sarcoma, lymphoma, and acute lymphoblastic leukaemia
Cisplatin (Causes DNA damage inhibiting replication of cancer cells). Works on Testicular, ovarian, bladder, lung, stomach, and head and neck cancers.
Docetaxel. Inhibits cell division, leading to the death of cancer cells. Works on Breast cancer, non-small cell lung cancer, prostate cancer, gastric cancer, and head and neck cancers.
Cyclophosphamide. Interfering with growth and replication of rapidly dividing cells. Leukaemia, lymphoma, breast cancer, ovarian cancer, and certain types of childhood cancers.
Methotrexate. Inhibiting enzyme dihydrofolate reductase, which is essential for DNA synthesis and cell replication. works on Leukaemia, lymphoma, and certain types of solid tumours.
Vinorelbine. Inhibiting the assembly of microtubules, thus preventing cell division. works on Non-small cell lung cancer and metastatic breast cancer.
siRNA Molecule. Silences gene expression by degrading mRNA molecules with complementary sequences, preventing the production of specific proteins. Therapeutic applications in treating genetic disorders and certain diseases by selectively inhibiting the production of disease-causing proteins
Through Our Science We Are Transforming Cancer Treatment for Chemotherapy Patients
